Atria Investments Inc acquired a new stake in Maximus, Inc. (NYSE:MMS – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,617 shares of the health services provider’s stock, valued at approximately $244,000.
Several other institutional investors have also added to or reduced their stakes in MMS. Vanguard Group Inc. lifted its holdings in shares of Maximus by 2.4% during the first quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after purchasing an additional 145,983 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Maximus by 2.1% during the 1st quarter. Janus Henderson Group PLC now owns 1,254,536 shares of the health services provider’s stock valued at $105,255,000 after acquiring an additional 25,825 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Maximus by 7.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider’s stock valued at $98,904,000 after acquiring an additional 79,092 shares during the last quarter. Van Berkom & Associates Inc. grew its stake in shares of Maximus by 0.8% in the second quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider’s stock worth $98,257,000 after acquiring an additional 8,811 shares during the period. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Maximus by 277.0% during the third quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock valued at $81,878,000 after purchasing an additional 645,760 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at approximately $607,841.52. This represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.40% of the company’s stock.
Maximus Stock Down 2.5 %
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.64%. Maximus’s payout ratio is 24.00%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories
- Five stocks we like better than Maximus
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Investing in the High PE Growth Stocks
- MarketBeat Week in Review – 11/18 – 11/22
- What Makes a Stock a Good Dividend Stock?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.